Bristol-Myers Squibb Raises 2026 Revenue Guidance After Q3 Beat

Third-quarter revenue rose 7.2% year over year to $13.1 billion, and non-GAAP earnings per share reached $1.35.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.